Form D · Biotechnology
SINAPIS PHARMA, INC.
Jacksonville, FL · CIK 0001492347
Offering snapshot reported Sep 19, 2014 · SEC filing
- Reported sold
- Yet to sell Offering amount: $3.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 19, 2014 | Initial | Yet to sell | No comparison | 5 | SEC filing |
| Apr 24, 2014 | Initial | $271,120 | No comparison | 5 | SEC filing |
| May 19, 2010 | Amendment | $511,234 | $0vs May 19, 2010 | 17 | SEC filing |
| May 19, 2010 | Initial | $511,234 | No comparison | 17 | SEC filing |
| May 19, 2010 | Initial | $311,163 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-225024
Source: Form D, filed Sep 19, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Howard C. Chandler, Jr. | Director, Executive |
| James Fonger | Executive |
| Albert Henry | Director |
| Donald Picker | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4350 Pablo Professional Court, Ste. 200
Jacksonville, FL, 32224
Jacksonville, FL, 32224